Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool June 1, 2007 Selena Maranjian	Ups and Downs for Women A new report on the progress of women in the workplace features some interesting results. Why does this topic matter to investors? Some studies suggest that having more women on a board of directors can lead to better governance.
The Motley Fool December 28, 2011 Alyce Lomax	1 Path to Better Boards in 2012 Strong companies require strong directors; diversity would help.
Entrepreneur October 2007 Mark Henricks	In the Mix How to attract - and keep - a diverse management team.
The Motley Fool November 2, 2011 Alyce Lomax	Corporate America's Feminine Mystique You've come a long way, baby... unfortunately, there's a ways to go yet.
CFO July 15, 2011 Marielle Segarra	Taking the Next Step Women who want to advance to the top spot in finance often need a sponsor. Here's why.
The Motley Fool February 16, 2011 Selena Maranjian	Women Execs Drive Winning Performance Three examples of successful companies with strong female leadership.
Pharmaceutical Executive April 1, 2014 William Looney	Dividing Lines Three examples this month show that, in our industry, there are always two sides at least to every question when we discuss who is your customer, health articles on Wikipedia, and diversity in the C-suite.
Pharmaceutical Executive February 1, 2006 Chandler & Chicco	Public Relations: Damage Control Unless pharma defines a compelling story, and defends it vigorously in the consumer marketplace, others will enter that vacuum and tell the story for it -- in far less flattering ways
Job Journal September 16, 2007 Michael Kinsman	Career Pros: Women Exit Workplace Exasperated Why talented women are tossing in the workplace towel.
Pharmaceutical Executive September 1, 2005 Bill Trombetta	2005 Industry Audit Who's really on top in the pharmaceutical industry?
U.S. Banker March 2011 Dalia Fahmy	Women on Board A U.K. initiative puts a spotlight on the dearth of female directors and gets corporate executives to commit to hard targets for improvement.
The Motley Fool January 5, 2011 Selena Maranjian	Why You Should Want More Women at the Top Studies show that boards with more women on them perform better.
Pharmaceutical Executive January 1, 2011 Walter Armstrong	The List It's a new year. Even pharma, with its glacial timelines, has its "Out with the old, in with the new" moment. Welcome to 2011!
U.S. Banker January 2003 Matthew DePaula	How Long Will Women Have to Wait? Women dominate the front lines of the financial industry, making up a majority of the employees. And yes, there are a lot of sharp women execs out there. But it's far more lonely at the top. Glass ceiling or slow going?
Pharmaceutical Executive November 1, 2006 Joanna Breitstein	Back Page: The Case for Diversity Variety is the spice of life - and the future of Big Pharma.
Job Journal November 4, 2007 Rich Heintz	The State of Diversity Success with diversity requires effectiveness from all people in the organization.
Pharmaceutical Executive March 1, 2011 Andrea LaFountain	Where have all the Scientists Gone? With an emphasis on short-term objectives rather than long-term goals, pharma is missing a huge opportunity in applying market science to drive adherence.
BusinessWeek October 27, 2003 Laura D'Andrea Tyson	New Clues To The Pay And Leadership Gap The problem for women is breaking through the glass ceiling, not getting equal compensation once they do so. So a nagging question remains: Why do so few women make it to the top corporate echelons?
The Motley Fool October 20, 2010 Alyce Lomax	This Secret Weapon Could Save Your Stocks The presence of women in the boardroom could be a little-known advantage for shareholders.
The Motley Fool October 30, 2011	Limited Seating: Mixed Results on Efforts to Include More Women at the Corporate Board Table A look at what advances are being made, and how.
BusinessWeek April 16, 2007 Diane Brady	A Little Shame Goes A Long Way Why Catalyst should go back to naming companies without women at the top.
Pharmaceutical Executive February 1, 2009 David Johnson	Dive into Digital Exclusive Pharma Exec survey details how pharma can make virtual channels effective marketing vehicles.
Pharmaceutical Executive April 10, 2014 Joanna Breitstein	HBA's Women of the Year 2014 The Healthcare Businesswomen's Association honored three female leaders this year. We take an in-depth look at each winner's background and career and what factors helped push them to the top of their game.
The Motley Fool September 16, 2011 Alyce Lomax	This Foreign Competition Could Do Us In Come on, America. Step into the future and let the ladies do their thing in the corporate setting.
Pharmaceutical Executive June 1, 2006 Philip A. George	Alternative Media: Online Med Sites Gain Patient Trust Pharma could benefit from a little less TV.
The Motley Fool January 15, 2009 Selena Maranjian	Female CEOs Are Taking Over Male CEOs should start coming up with alternative plans.
AFP eWire November 7, 2005	Gender Pay Gap Narrows at U.S. Charities, But Still Remains Unequal A new study reveals that despite increases, men continue to earn more than their female counterparts, with the median salary for a male CEO of a charity with a budget of $50 million or more $332,985 compared to $262,275 for a female CEO.
CFO July 15, 2009 Kate O'Sullivan	Power Struggle Will the recession short-circuit women's advancement to the top spots in finance?
Pharmaceutical Executive October 1, 2005	Public Relations: Communications Delivery Chain An interview with Nanccy Turett, president of Edelman Health on how, to regain consumers' trust, pharma must better communicate its mission, goals, and policies.
Pharmaceutical Executive January 1, 2009 Stan Bernard	Pharma vs. Pharma The most successful pharmaceutical companies will be those that can transform as the industry itself transforms.
Pharmaceutical Executive April 1, 2011 William Looney	Platforms for Peerless Performance A true performance culture has to focus on the mundane as much as the sublime.
Bio-IT World November 2005 Charles Firneno	The Information Value Chain By looking at the evolution of pharma's information networks, strategies can be designed for IT solutions such as CRM, CTMS, AERSs, and business analytics software to deliver the highest possible value.
Pharmaceutical Executive October 1, 2008 Patrick Clinton	Future Shock A vision of pharma's next business model is starting to emerge. But how do we get from here to there?
Pharmaceutical Executive January 1, 2009 Stephen E. Gerard	Pharma Confidential In these tough times, how does pharma see its future? How confident are top executives in the future of the industry and their own company? Does size make a difference? Operations executives from a cross section of large, mid-tier, and specialty companies answer these questions and more.
Pharmaceutical Executive August 1, 2011 Bill Drummy	The Slow Dance Toward Obsolescence Does Big Pharma have the emotional connection and intellectual commitment to move with the pace of change?
U.S. Banker	The Calm Amid the Storm The 25 most powerful women in banking.
The Motley Fool November 24, 2006 Selena Maranjian	Women on Board, for Better Governance A 2006 study found that a critical mass of three or more women can cause a fundamental change in the boardroom and enhance corporate governance. Why is this important to investors?
Chemistry World September 11, 2014 Emma Stoye	Pharma sales 'will reach $1 trillion' in 2014 Global sales in the pharmaceutical industry are set to go over the $1 trillion mark this year, according to a report by Thomson Reuters.
Pharmaceutical Executive April 1, 2007	Sales Management: The New BioPharma Representative With today's sales force in flux, pharma is looking to a new sales elite.
Pharmaceutical Executive October 1, 2011	Arming up for the Digital Revolution As a longtime advocate of new approaches to meeting customer needs in pharma, Martin Wygod sees the biggest change as the coming growth of digital platforms as the principal source of information and communication in healthcare.
Pharmaceutical Executive December 1, 2006 Ragnar Lofstedt	Back Page: The Post-Trust World People no longer put their faith in industry or regulators. What can we do about that? A good start would be understanding the human side of risk.
Pharmaceutical Executive August 1, 2011 Peter Houston	Google+ and Pharma Is Google+ the social media platform that pharma has been waiting for?
Pharmaceutical Executive May 1, 2005	Thought Leaders: Playing Field in Biotech/Pharma Partnerships Levels As infrastructure and business savvy within biotechs become increasingly sophisticated, the sector's relationship with pharma is taking on a new shape. An interview with industry veteran Lisa Drakeman on how to integrate cultures and processes and where pharma is falling short.
U.S. Banker May 2010 Alan Kline	Programs are Important, But It's Results That Matter Lots of companies have programs aimed at grooming more female executives, but that doesn't mean much if C-suites are still dominated by men.
Pharmaceutical Executive April 1, 2007 Porth & Sillup	Media Audit: Stop the Presses! The media are becoming more negative and one-sided when it comes to reporting pharmaceutical industry news.
Pharmaceutical Executive March 1, 2013 Sillup et al.	Back in the News Big Pharma takes a fresh licking in our latest audit of US press coverage of business and policy issues.
Pharmaceutical Executive April 1, 2007 Bill Trombetta	Stealth Pharmas Big Pharma is different from the thousands of biotechs, specialty pharmas, generics makers, and other companies that make up Stealth Pharma. Yes, they have more money. But in what other ways are they different? And can we learn anything from the way Stealth Pharma competes?
Pharmaceutical Executive January 1, 2012	Compliance: Getting Those Ducks in a Row Pharma must coordinate the efforts of medical, legal, HR, global partners and many other players in the regulatory compliance space to keep itself afloat in choppy seas.
Pharmaceutical Executive January 1, 2007 Glass & Poli	Forecast 2007: Connecting the Dots How do execs rank the issues facing the pharmaceutical industry? And what are the links they see between them? A new study reveals the industry's mental map of today's challenges.
Pharmaceutical Executive January 1, 2011	The Steep, Slow Climb A survey of leading experts reveals 2011's sobering reality and the trends that smart drugmakers will follow into the next decade.